CVTOX

Product NDC
43857-0325
11-digit product format
438570325
Labeler code
43857
Product ID
43857-0325_ad3157d8-0ccb-4ffa-9799-955200552271
Type
HUMAN OTC DRUG
Nonproprietary name
Cochlearia Armoracia, Echinacea (Angustifolia), Hydrastis Canadensis, Lomatium Dissectum, Tabebuia Impetiginosa, Propolis, Glandula Suprarenalis Bovine, Thymus (Suis), Aranea Diadema, Ipecacuanha, Lycopodium Clavatum, Muriaticum Acidum, Nitricum Acidum, Phosphoricum Acidum, Rhus Tox, Silicea, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Herpes Zoster Nosode, Morbillinum, Poliomyelitis Nosode, Hepatitis B Nosode, Coxsackie B1 Nosode, Coxsackie B4 Nosode
Dosage form
LIQUID
Route
ORAL
Labeler
BioActive Nutritional, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2014-08-04
Marketing end
2020-04-20
Substance
HORSERADISH; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; LOMATIUM DISSECTUM ROOT; TABEBUIA IMPETIGINOSA BARK; PROPOLIS WAX; BOS TAURUS ADRENAL GLAND; SUS SCROFA THYMUS; ARANEUS DIADEMATUS; IPECAC; LYCOPODIUM CLAVATUM SPORE; HYDROCHLORIC ACID; NITRIC ACID; PHOSPHORIC ACID; TOXICODENDRON PUBESCENS LEAF; SILICON DIOXIDE; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 3; MEASLES VIRUS; POLIOVIRUS; HEPATITIS B VIRUS; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4
Active strength
3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; 1/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record